Search

Collegium Pharmaceutical Inc

Gesloten

SectorGezondheidszorg

27.33 0.48

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

26.69

Max

27.95

Belangrijke statistieken

By Trading Economics

Inkomsten

-30M

-15M

Verkoop

6.4M

200M

K/W

Sectorgemiddelde

22.228

57.371

EPS

1.57

Winstmarge

-7.53

Werknemers

423

EBITDA

-20M

71M

Aanbevelingen

By TipRanks

Aanbevelingen

Strong Buy

12 Maanden Prognose

+81.67% upside

Dividenden

By Acuity

Volgende Winsten

5 nov 2026

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-279M

875M

Vorige openingsprijs

26.85

Vorige sluitingsprijs

27.33

Nieuwssentiment

By Acuity

32%

68%

104 / 340 Rangschikking in Healthcare

Collegium Pharmaceutical Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

24 aug 2026, 22:02 UTC

Collegium Pharmaceutical shares advanced in after-market trading, despite being below their 20-day moving average and weaker compared to a month ago.

21 aug 2026, 20:13 UTC

Collegium Pharmaceutical Inc. shares are trading roughly flat after-market, with no specific news identified. The stock remains below its 20-day moving average.

20 aug 2026, 20:01 UTC

Collegium Pharmaceutical shares are lower amid broader market pressures, reflecting negative sentiment following Walmart's disappointing earnings report.

19 aug 2026, 19:56 UTC

Collegium Pharmaceutical Inc. shares are higher since Tuesday's close, reaching a session high earlier before pulling back within routine trading patterns.

18 aug 2026, 19:56 UTC

Collegium Pharmaceutical Inc is trading higher today, though no specific news was identified to explain the movement. The stock remains below its 20-day moving average.

17 aug 2026, 19:36 UTC

Collegium Pharmaceutical Inc shares are higher during Monday's session, reaching a peak gain earlier today before retracing. No specific news was identified for the movement.

14 aug 2026, 19:21 UTC

Collegium Pharmaceutical Inc shares are lower today, reflecting a broader downturn in the Pharmaceuticals sector. The stock remains below its 20-day moving average.

13 aug 2026, 22:51 UTC

Collegium Pharmaceutical Inc shares rose in after-market trading, reflecting broader market gains amid unchanged producer prices and easing inflation expectations.

12 aug 2026, 19:51 UTC

Collegium Pharmaceutical Inc's shares are lower today, continuing a trend of recent weakness amid unusually high market volume. No specific news was identified.

11 aug 2026, 22:01 UTC

Collegium Pharmaceutical Inc shares are higher in after-market trading, reversing earlier session dips and showing strength after three consecutive lower closes.

10 aug 2026, 21:01 UTC

Collegium Pharmaceutical Inc shares are lower in after-market hours, continuing a trend since Monday's close, and are significantly below their 20-day moving average.

7 aug 2026, 21:01 UTC

Collegium Pharmaceutical Inc shares are trading higher in after-market hours. No specific news was identified to explain the movement.

6 aug 2026, 23:11 UTC

Collegium Pharmaceutical Inc shares are higher in after-market hours, recovering from an initial dip but remain below their 20-day moving average.

4 aug 2026, 19:26 UTC

Collegium Pharmaceutical Inc shares are lower today, trading near the lower end of their one-month range, with no specific news driving the decline.

3 aug 2026, 19:46 UTC

Collegium Pharmaceutical Inc is trading lower today, continuing a three-session decline. The stock peaked early but has since pulled back.

31 jul 2026, 20:06 UTC

News

Collegium Pharmaceutical is under scrutiny due to concerns over its financial performance, contributing to a decline in shares during Friday's session.

30 jul 2026, 20:09 UTC

Collegium Pharmaceutical Inc shares are lower in Thursday's session, with no specific news to explain the decline amid broader market volatility.

29 jul 2026, 22:01 UTC

Collegium Pharmaceutical Inc is trading higher in after-market hours, continuing a positive trend with gains over four consecutive sessions amid cautious investor sentiment.

28 jul 2026, 22:01 UTC

Collegium Pharmaceutical Inc shares are lower in after-market hours, continuing a decline from Tuesday's close amid broader market pressures, particularly in Asia.

27 jul 2026, 19:07 UTC

News

Collegium Pharmaceutical reported first-quarter revenues of $193.5 million, surpassing expectations, while shares are trading higher amid broader strength in the pharmaceutical sector.

24 jul 2026, 19:46 UTC

Collegium Pharmaceutical Inc shares are lower during Friday's session, with no specific news identified to explain the decline. The stock remains near its one-month trading range.

22 jul 2026, 20:01 UTC

Collegium Pharmaceutical Inc shares are lower today, continuing a downward trend seen since Tuesday's close, with no specific news identified for the decline.

21 jul 2026, 20:01 UTC

Collegium Pharmaceutical Inc is trading higher amid a broader market rally, with the Pharmaceuticals sector also gaining momentum. No specific news was identified.

20 jul 2026, 19:41 UTC

News

Collegium Pharmaceutical plans to move its headquarters to Boston in 2027. Shares are lower amid significant declines in the Pharmaceuticals sub-sector.

Peer Vergelijking

Prijswijziging

Collegium Pharmaceutical Inc Prognose

Koersdoel

By TipRanks

81.67% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 49.25 USD  81.67%

Hoogste 60 USD

Laagste 43 USD

Gebaseerd op 4 Wall Street-analisten die 12-maands prijsdoelen bieden voor Collegium Pharmaceutical Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

4 ratings

3

Buy

1

Hold

0

Sell

Sentiment

By Acuity

104 / 340 Rangschikking in Gezondheidszorg

Nieuwssentiment

Bullish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Boven gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Collegium Pharmaceutical Inc

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, and oral formulation of oxycodone for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol, indicated for the management of acute, severe, and persistent pain; Belbuca, a buccal film that contains buprenorphine; and Symproic, an oral formulation of naldemedine for the treatment of opioid-induced constipation in adult patients with chronic non-cancer pain. The company was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. Collegium Pharmaceutical, Inc. was incorporated in 2002 and is headquartered in Stoughton, Massachusetts.
help-icon Live chat